Survey of treatment practices for immunocompromised patients with COVID-19 in Australasia

被引：5
作者：
Moso, Michael A. [1 ,2 ,3 ]
Sasadeusz, Joe [1 ,3 ]
Morrissey, Catherine O. [4 ,5 ]
Bond, Katherine [2 ,6 ]
Guy, Stephen [7 ,8 ]
Slavin, Monica A. [1 ,10 ,11 ]
Dendle, Claire [9 ,12 ,13 ]
机构：
[1] Royal Melbourne Hosp, Victorian Infect Dis Serv, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia
[2] VIDRL Peter Doherty Inst Infect & Immun, Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Infect Dis, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia
[4] Alfred Hlth, Dept Infect Dis, Melbourne, Vic, Australia
[5] Monash Univ, Melbourne, Vic, Australia
[6] Royal Melbourne Hosp, Dept Microbiol, Melbourne, Vic, Australia
[7] Eastern Hlth, Dept Infect Dis, Melbourne, Vic, Australia
[8] Eastern Hlth Clin Sch, Melbourne, Vic, Australia
[9] Monash Univ, Sch Clin Sci, Melbourne, Australia
[10] Peter MacCallum Canc Ctr, Dept Infect Dis, Melbourne, Vic, Australia
[11] Peter MacCallum Canc Ctr, Natl Ctr Infect Canc, Melbourne, Vic, Australia
[12] Monash Hlth, Monash Infect Dis, Melbourne, Vic, Australia
[13] Monash Med Ctr, Monash Infect Dis, 246 Clayton Rd, Clayton, Vic, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2023年 / 53卷 / 04期
关键词：
COVID-19; immunocompromised; survey; antivirals; transplant; malignancy;
D O I：
10.1111/imj.16064
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Coronavirus disease 2019 (COVID-19) in immunocompromised patients can lead to severe and prolonged illness. Data are limited with regard to management of COVID-19 in this setting, particularly in persistent or recrudescent infection. The authors conducted an online survey among infectious diseases doctors to determine current approaches to treatment across Australasia. There was marked variability in responses relating to the diagnostic modalities and use of antiviral agents in patients with immunocompromise, highlighting the need for high-quality studies to guide treatment decisions in this group.
引用
收藏
页码：619 / 624
页数：6
相关论文
共 32 条
  • [11] De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report
    Gandhi, Shiv
    Klein, Jonathan
    Robertson, Alexander
    Pena-Hernandez, Mario A.
    Lin, Michelle J.
    Roychoudhury, Pavitra
    Lu, Peiwen
    Fournier, John
    Ferguson, David
    Bakhash, Shah A. Mohamed
    Muenker, M. Catherine
    Srivathsan, Ariktha
    Wunder, Elsio A., Jr.
    Kerantzas, Nicholas
    Wang, Wenshuai
    Lindenbach, Brett
    Pyle, Anna
    Wilen, Craig B.
    Ogbuagu, Onyema
    Greninger, Alexander L.
    Iwasaki, Akiko
    Schulz, Wade L.
    Ko, Albert, I
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [12] Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis
    Gatti, Milo
    Rinaldi, Matteo
    Bussini, Linda
    Bonazzetti, Cecilia
    Pascale, Renato
    Pasquini, Zeno
    Fani, Francesca
    Pinho Guedes, Mariana Nunes
    Azzini, Anna Maria
    Carrara, Elena
    Palacios-Baena, Zaira R.
    Caponcello, Giulia
    Reyna-Villasmil, Eduardo
    Tacconelli, Evelina
    Rodriguez-Bano, Jesus
    Viale, Pierluigi
    Giannella, Maddalena
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (08) : 1057 - 1065
  • [13] Repeated Coronavirus Disease 2019 Molecular Testing: Correlation of Severe Acute Respiratory Syndrome Coronavirus 2 Culture With Molecular Assays and Cycle Thresholds
    Gniazdowski, Victoria
    Morris, C. Paul
    Wohl, Shirlee
    Mehoke, Thomas
    Ramakrishnan, Srividya
    Thielen, Peter
    Powell, Harrison
    Smith, Brendan
    Armstrong, Derek T.
    Herrera, Monica
    Reifsnyder, Carolyn
    Sevdali, Maria
    Carroll, Karen C.
    Pekosz, Andrew
    Mostafa, Heba H.
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 73 (04) : E860 - E869
  • [14] Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
    Goldman, Jason D.
    Lye, David C. B.
    Hui, David S.
    Marks, Kristen M.
    Bruno, Raffaele
    Montejano, Rocio
    Spinner, Christoph D.
    Galli, Massimo
    Ahn, Mi-Young
    Nahass, Ronald G.
    Chen, Yao-Shen
    SenGupta, Devi
    Hyland, Robert H.
    Osinusi, Anu O.
    Cao, Huyen
    Blair, Christiana
    Wei, Xuelian
    Gaggar, Anuj
    Brainard, Diana M.
    Towner, William J.
    Munoz, Jose
    Mullane, Kathleen M.
    Marty, Francisco M.
    Tashima, Karen T.
    Diaz, George
    Subramanian, Aruna
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (19) : 1827 - 1837
  • [15] Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
    Hammond, Jennifer
    Leister-Tebbe, Heidi
    Gardner, Annie
    Abreu, Paula
    Bao, Weihang
    Wisemandle, Wayne
    Baniecki, MaryLynn
    Hendrick, Victoria M.
    Damle, Bharat
    Simon-Campos, Abraham
    Pypstra, Rienk
    Rusnak, James M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (15) : 1397 - 1408
  • [16] Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase atrial
    Holland, Thomas L.
    Ginde, Adit A.
    Paredes, Roger
    Murray, Thomas A.
    Engen, Nicole
    Grandits, Greg
    Vekstein, Andrew
    Ivey, Noel
    Mourad, Ahmad
    Sandkovsky, Uriel
    Gottlieb, Robert L.
    Berhe, Mezgebe
    Jain, Mamta K.
    Marines-Price, Rubria
    Agbor, Barbine Tchamba Agbor
    Mateu, Lourdes
    Espana-Cueto, Sergio
    Llados, Gemma
    Mylonakis, Eleftherios
    Rogers, Ralph
    Shehadeh, Fadi
    Filbin, Michael R.
    Hibbert, Kathryn A.
    Kim, Kami
    Tran, Thanh
    Morris, Peter E.
    Cassity, Evan P.
    Trautner, Barbara
    Pandit, Lavannya M.
    Knowlton, Kirk U.
    Leither, Lindsay
    Matthay, Michael A.
    Rogers, Angela J.
    Drake, Wonder
    Jones, Beatrice
    Poulakou, Garyfallia
    Syrigos, Konstantinos N.
    Fernandez-Cruz, Eduardo
    Di Natale, Marisa
    Almasri, Eyad
    Balerdi-Sarasola, Leire
    Bhagani, Sanjay R.
    Boyle, Katherine L.
    Casey, Jonathan D.
    Chen, Peter
    Douin, David J.
    Files, D. Clark
    Gunthard, Huldrych F.
    Hite, R. Duncan
    Hyzy, Robert C.
    [J]. LANCET RESPIRATORY MEDICINE, 2022, 10 (10) : 972 - 984
  • [17] Culture-Based Virus Isolation To Evaluate Potential Infectivity of Clinical Specimens Tested for COVID-19
    Huang, Chung-Guei
    Lee, Kuo-Ming
    Hsiao, Mei-Jen
    Yang, Shu-Li
    Huang, Peng-Nien
    Gong, Yu-Nong
    Hsieh, Tzu-Hsuan
    Huang, Po-Wei
    Lin, Ya-Jhu
    Liu, Yi-Chun
    Tsao, Kuo-Chien
    Shih, Shin-Ru
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (08)
  • [18] Correlation Between 3790 Quantitative Polymerase Chain Reaction-Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 Isolates
    Jaafar, Rita
    Aherfi, Sarah
    Wurtz, Nathalie
    Grimaldier, Clio
    Hoang, Van Thuan
    Colson, Philippe
    Raoult, Didier
    La Scola, Bernard
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 72 (11) : E921 - E922
  • [19] Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards
    La Scola, Bernard
    Le Bideau, Marion
    Andreani, Julien
    Hoang, Van Thuan
    Grimaldier, Clio
    Colson, Philippe
    Gautret, Philippe
    Raoult, Didier
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2020, 39 (06) : 1059 - 1061
  • [20] National COVID-19 Clinical Evidence Taskforce, AUSTR GUID CLIN CAR
1234